ATE541835T1 - Neue inhibitoren von glutaminylcyclase - Google Patents
Neue inhibitoren von glutaminylcyclaseInfo
- Publication number
- ATE541835T1 ATE541835T1 AT05707206T AT05707206T ATE541835T1 AT E541835 T1 ATE541835 T1 AT E541835T1 AT 05707206 T AT05707206 T AT 05707206T AT 05707206 T AT05707206 T AT 05707206T AT E541835 T1 ATE541835 T1 AT E541835T1
- Authority
- AT
- Austria
- Prior art keywords
- impaired
- glutaminyl cyclase
- sleep
- regulation
- disease
- Prior art date
Links
- 102000003642 glutaminyl-peptide cyclotransferase Human genes 0.000 title abstract 2
- 108010081484 glutaminyl-peptide cyclotransferase Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000001771 impaired effect Effects 0.000 abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 208000007848 Alcoholism Diseases 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 201000010374 Down Syndrome Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 206010062519 Poor quality sleep Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000037424 autonomic function Effects 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 230000008482 dysregulation Effects 0.000 abstract 1
- 230000037149 energy metabolism Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 235000012631 food intake Nutrition 0.000 abstract 1
- 230000003284 homeostatic effect Effects 0.000 abstract 1
- 230000003054 hormonal effect Effects 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54213304P | 2004-02-05 | 2004-02-05 | |
| US10/838,993 US7371871B2 (en) | 2003-05-05 | 2004-05-05 | Inhibitors of glutaminyl cyclase |
| US63436404P | 2004-12-08 | 2004-12-08 | |
| PCT/EP2005/001153 WO2005075436A2 (en) | 2004-02-05 | 2005-02-04 | Novel inhibitors of glutaminyl cyclase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE541835T1 true ATE541835T1 (de) | 2012-02-15 |
Family
ID=42121404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05707206T ATE541835T1 (de) | 2004-02-05 | 2005-02-04 | Neue inhibitoren von glutaminylcyclase |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | ATE541835T1 (de) |
| DK (1) | DK1713780T3 (de) |
| EA (1) | EA013790B1 (de) |
| IL (1) | IL176765A (de) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS605593B2 (ja) * | 1981-03-20 | 1985-02-12 | 北興化学工業株式会社 | イミダゾ−ル誘導体および農園芸用殺菌剤 |
| WO1997043278A1 (en) * | 1996-05-14 | 1997-11-20 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| DK1032556T3 (da) * | 1997-10-21 | 2008-03-25 | Wyeth Corp | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder |
| HUP0302962A2 (hu) * | 1998-06-12 | 2003-12-29 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása |
| CA2417507A1 (en) * | 2000-08-21 | 2002-02-28 | Pacific Corporation | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| SE0100566D0 (sv) * | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| WO2004098591A2 (en) * | 2003-05-05 | 2004-11-18 | Probiodrug Ag | Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| CN1784220B (zh) * | 2003-05-05 | 2011-08-03 | 前体生物药物股份公司 | 谷氨酰胺酰基和谷氨酸环化酶效应物的应用 |
-
2005
- 2005-02-04 EA EA200601411A patent/EA013790B1/ru not_active IP Right Cessation
- 2005-02-04 AT AT05707206T patent/ATE541835T1/de active
- 2005-02-04 DK DK05707206.8T patent/DK1713780T3/da active
-
2006
- 2006-07-10 IL IL176765A patent/IL176765A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| HK1100943A1 (en) | 2007-10-05 |
| DK1713780T3 (da) | 2012-05-07 |
| IL176765A (en) | 2011-08-31 |
| IL176765A0 (en) | 2006-10-31 |
| EA013790B1 (ru) | 2010-06-30 |
| EA200601411A1 (ru) | 2007-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005075436A3 (en) | Novel inhibitors of glutaminyl cyclase | |
| ATE462432T1 (de) | Glutaminylcyclase-hemmer | |
| ECSP066336A (es) | Derivados de 3-amino croman y 2-amino tetralin | |
| MX2007012374A (es) | Metodos y composiciones para el tratamiento de condiciones relacionadas con cns. | |
| CL2010001173A1 (es) | Compuestos derivados de 1,4-diazepam sustituido, antagonistas de ox1 y ox2; utiles para preparar un medicamento destinado al tratamiento o prevencion de un trastorno del sueño,para potenciar la calidad del sueno,y para tratar o controlar la obesidad.(divisional de la sol.n 3441-07) | |
| CY1111206T1 (el) | Βενζοθειοφαινια υποκατεστημενα με πιπεραζινη για την αγωγη διανοητικων διαταραχων | |
| EP1881823A4 (de) | Zusammensetzungen und verfahren zur behandlung von augenleiden | |
| EP2096919A4 (de) | Substituierte 2,3-dihydroimidazo[1,2-c]chinazolinderivate, die sich für die behandlung von hyperproliferativen störungen und mit angiogenese in zusammenhang stehenden krankheiten eignen | |
| WO2008021210A3 (en) | Methods and compositions for the treatment of neurodegenerative disorders | |
| EA200802054A1 (ru) | Ингибиторы фермента | |
| NZ595571A (en) | Pyrazole compounds and uses thereof | |
| EA200801934A1 (ru) | 1,4-двузамещённые 3-циано-пиридоновые производные и их применение в качестве позитивных модуляторов рецепторов mglur2 | |
| DE602007001893D1 (en) | Aryl-4-ethinylisoxazolderivate | |
| TNSN08205A1 (en) | Use of a cb1 antagonist for treating negative symptoms of schizophrenia | |
| WO2007009083A3 (en) | Compounds with activity at retinoic acid receptors | |
| SG157231A1 (en) | Substituted p-diaminobenzene derivatives | |
| WO2005099702A3 (en) | R(-)-11-hydroxyaporphine derivatives and uses thereof | |
| DK1670903T3 (da) | Behandling af neurodegenerative sygdomme | |
| WO2008057575A3 (en) | Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use | |
| BRPI0411864A (pt) | combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| WO2010080757A3 (en) | Combinations with an alpha-4beta-2 nicotinic agonist | |
| TW200735878A (en) | Pharmaceutical compositions | |
| EP1812078A4 (de) | Kinasehemmer zur behandlung von diabetes und adipositas | |
| ATE552251T1 (de) | Thiophen- und furanverbindungen | |
| ATE541835T1 (de) | Neue inhibitoren von glutaminylcyclase |